Breastfeeding and migraine drugs

@article{Davanzo2014BreastfeedingAM,
  title={Breastfeeding and migraine drugs},
  author={Riccardo Davanzo and Jenny Bua and Giulia Paloni and Giulia Facchina},
  journal={European Journal of Clinical Pharmacology},
  year={2014},
  volume={70},
  pages={1313-1324}
}
PurposeBreastfeeding women may suffer from migraine. While we have many drugs for its treatment and prophylaxis, the majority are poorly studied in breastfeeding women. We conducted a review of the most common anti-migraine drugs (AMDs) and we determined their lactation risk.MethodsFor each AMD, we collected all retrievable data from Hale’s Medications and Mother Milk (2012), from the LactMed database (2014) of the National Library of Medicine, and from a MedLine Search of relevant studies… Expand
Pharmacological treatment of migraine during pregnancy and breastfeeding
TLDR
Current evidence of the safety of the most common antimigraine medications during pregnancy and breastfeeding is summarized, and treatment recommendations for use in clinical practice are provided. Expand
Consensus of the Brazilian Headache Society on the treatment of chronic migraine.
TLDR
Oral topiramate and onabotulinum toxin A injections are the only treatments granted Class A recommendation, while valproate, gabapentin, and tizanidine received Class B recommendation, along with acupuncture, biofeedback, and mindfulness. Expand
Women and Migraine: the Role of Hormones
TLDR
An overview of a woman’s migraine throughout her lifetime, the impact of hormones and an approach to management is provided. Expand
Drug safety and tolerability in prophylactic migraine treatment
TLDR
The background of the recurrence and chronification of migraine attacks has not been fully clarified, and causative preventive therapy is therefore not currently available, and the tolerability and adverse effects of the currently used medications often limit their use. Expand
Drug safety in acute migraine treatment
TLDR
The frequent use of analgesics, ergot alkaloids and triptans may result in the development of medication overuse headache (MOH), and there is a need for pathomechanism-based drugs, and for the future achievement of personalized medicine. Expand
Drug Principles in Lactation
TLDR
Current recommendations include exclusively breastfeeding through 6 months of age and then continuing to predominantly breastfeed (supplementing with water or water-based liquids) or partly breastfed (adding in other liquids and solids) through 1 year or older. Expand
Codeine Precipitating Serotonin Syndrome in a Patient in Therapy with Antidepressant and Triptan
TLDR
The development of syntomatology, the clinical examination and the possible pharmacokinetics explanation were carefully discussed and analysed and the patient was diagnosed as a probable case of serotonin syndrome due to a pharmacological interaction between venlafaxine and rizatriptan trigged by opioid intake. Expand
Migraine in Women.
TLDR
It is important for clinicians to have a good understanding of the impact of the hormonal fluctuations that occur throughout a female migraineur's life, so that appropriate, stratified therapies can be implemented. Expand
Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing
TLDR
Rodent research has the potential to forecast impairments in breastfed children long before information emerges from post-marketing reports and should be prioritized during preclinical drug evaluation by the FDA for new drugs and for drugs currently prescribed off-label for lactating women. Expand
Advising Mothers on the Use of Medications during Breastfeeding
TLDR
To foster an appropriate approach toward the use of medications in breastfeeding women, the Italian Society of Perinatal Medicine created the following policy statement. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 130 REFERENCES
Antiepileptic drugs and breastfeeding
TLDR
Most AEDs can be considered safe during breastfeeding according to this review, and gabapentin, lamotrigine, oxcarbazepine, vigabatrin, tiagabine, pregabalin, leviracetam and topiramate are compatible with breastfeeding with a less documented safety profile. Expand
Antidepressant drugs and breastfeeding: a review of the literature.
TLDR
A systematic review of drugs commonly used in the treatment of postpartum depression found that knowledge of pharmacokinetic characteristics are scarcely useful to assess safety and the majority of antidepressants are not usually contraindicated. Expand
Use of Psychotropic Medications in Treating Mood Disorders during Lactation
TLDR
Current data on drug excretion into breast milk and the effects on the breast-fed child, and recommendations for the use of the different psychotropic drugs in lactating women are reviewed. Expand
Anticonvulsant Use During Lactation
TLDR
The issue of prescribing anticonvulsant drugs during lactation is clinically important, but also complex and no clearcut recommendations can be made until further data are present. Expand
Pharmacological treatment of unipolar depression during pregnancy and breast-feeding—A clinical overview
TLDR
This overview is aimed at clinicians working with patients in the fertile age who suffer from depressive disorders, and finds that citalopram and sertraline can be used during pregnancy, while some controversy remains over in utero exposure to paroxetines and fluoxetine, which might be associated with an increased risk of foetal cardiovascular malformation. Expand
Antirheumatic medication during lactation.
TLDR
The infant should be closely monitored if antimalarials are being used by lactating women, and the choice of NSAIDs would be between a short half-life propionic acid derivative, with little biotransformation, such as ibuprofen or flurbiprofen. Expand
Safety of triptans for migraine headaches during pregnancy and breastfeeding.
TLDR
Information regarding safety of triptans while breastfeeding is limited but also reassuring, as the minimal amounts excreted into the milk are insufficient to cause any adverse effects on the breastfeeding infant. Expand
Anticonvulsants and breast feeding: a critical review.
TLDR
Weighing the benefits of breast feeding against the potential risk to the nursing infant, breast feeding is considered to be safe when the mother is taking carbamazepine, valproic acid or phenytoin; however, observation for adverse effects is recommended. Expand
Mood stabilizers during breastfeeding: a review.
TLDR
It is proposed that a woman's historical response to medication and the clinical circumstances be the primary considerations when choosing a mood stabilizer during breastfeeding, rather than strict adherence to categorical assignments. Expand
Anticonvulsants and Breast Feeding
TLDR
Weighing the benefits of breast feeding against the potential risk to the nursing infant, breast feeding is considered to be safe when the mother is taking carbamazepine, valproic acid or phenytoin, and infant monitoring for potential adverse effects is advisable. Expand
...
1
2
3
4
5
...